SARS CoV-2 aggravates cellular metabolism mediated complications in COVID-19 infection. by Singh, Y et al.
"This is the peer reviewed version of the following article: [Dermatologic therapy, 2020, pp. e13871] 
which has been published in final form at [https://onlinelibrary.wiley.com/doi/10.1111/dth.13871 
] purposes in accordance with Wiley Terms and Conditions for Self-Archiving." 
 
This article has been accepted for publication and undergone full peer review but has not been 
through the copyediting, typesetting, pagination and proofreading process which may lead to 
differences between this version and the Version of Record. Please cite this article as doi: 
10.1111/dth.13871 
 
SARS CoV-2 aggravates cellular metabolism mediated complications in COVID-19 
infection 
Yogendra Singh 1, Gaurav Gupta 2,  Imran Kazmi 3, Fahad A. Al-Abbasi 3, Poonam Negi 4, 
Dinesh Chellappan 5, Kamal Dua 6, 7, 8 
1. Mahatma Gandhi College of Pharmaceutical Sciences, Sitapura, Jaipur, India 
2. School of Pharmacy, Suresh Gyan Vihar University, Mahal Road, Jagatpura, Jaipur, India 
3. Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, 
Saudi Arabia 
4. School of Pharmaceutical Sciences, Shoolini University, Solan, Himachal Pradesh, India 
5. Department of Life Sciences, School of Pharmacy, International Medical University, 
Bukit Jalil, Kuala Lumpur, Malaysia 57000 
6. Centre for Inflammation, Centenary Institute, Sydney, NSW 2050, Australia. 
7. Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) 
& School of Biomedical Sciences and Pharmacy, The University of Newcastle (UoN), 
Callaghan, NSW 2308, Australia. 
8.  Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney 
(UTS), Ultimo, NSW 2007, Australia. 
 
Corresponding Author: Gaurav Gupta, School of Pharmacy, Suresh Gyan Vihar University, 
Mahal Road, Jagatpura, Jaipur, India. Email id: gauravpharma25@gmail.com 
This article is protected by copyright. All rights reserved.




Dear Editor,  
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the primary causative 
organism in corona virus disease-19 (COVID-19) infections, is a novel member of the human 
coronavirus (CoVs) family which was first identified in Wuhan, China, towards the end of 2019. 
According to the WHO situation report as on 11th May, there were 4 006 257 positive cases (88 
891) and 278 892 deaths (4531) that have been reported.  
Taxonomically, SARS-CoV-2 is a type of Beta-CoV composed of the lineage B which is closely 
related to coronaviruses that are transmitted through bats, with a 96% overall identity  . The virus 
is now known to infect host cells through a mechanism that interacts with the angiotensin-
converting enzyme-2 (ACE2) receptors largely found on the plasma membranes of the epithelial 
cells in the respiratory tract  and upper esophagus. The virus also infects several other cell types, 
namely, stratified cells of the epithelium, colonic and ileum based enterocytes that are absorptive 
in function, specialized cells like cholangiocytes, proximal tubule cells of the nephron, urothelial 
cells in the urinary bladder and cardiac myocardial cells 1. The SARS-CoV-2 is involved in 
various complications including pneumonia, cardiovascular disease, renal injury, ischemic stroke  
and neurodegenerative process 2.  
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Recent findings from the published studies have revealed that there is an unusual rise in several 
biochemical parameters in the infected subjects, namely, serum ferritin levels, erythrocyte 
sedimentation rate, levels of C-reactive protein, albumin levels and lactate dehydrogenase levels. 
These would also imply that the haemoglobin levels in these subjects may be on the decline, as 
the blood and tissues accumulate increased levels of harmful chemicals due to the manifestations 
of the viral proteins that coordinately attack the heme substance in the hemoglobin 3. A Wuhan 
case report involving a total of 99 subjects who were infected with COVID-19 reported 38% 
increase in neutrophil number; 52% increase in the level of Interluekin-6 (IL-6) and 86% 
increase in the levels of c-reactive protein. In addition, there was also a 35% decrease in the level 
of total lymphocytes 4. In addition, it was also reported that these complications resulted in a 
‘cytokine storm’ leading to multiple organ failure.  
GenBank entries of 1b genomic sequences of alpha-, beta-, and gamma CoVs, which were 
extracted with Open Reading Frames (ORFs), demonstrated that the SARS-CoV-2 is critically 
dependent on the binding with S-adenosyl-L-methionine (SAM). Furthermore, it is now evident 
that the nonstructural protein (nsp) 14 of SARS coronavirus is a (guanine-N7)-methyltransferase 
(N7-MTase). The SAM binding motif is reported to be specifically significant among these 
nsp14 N7-MTase regions of coronaviruses. Mutations have been previously reported in these 
domains of SARS-CoV nsp14 ablate N7-MTase giving rise to a new infective mode of 
mechanism in the coronaviruses 5. Studies on the mechanisms of mutation in a replicon model 
revealed that the mechanism involving the N7-MTase was crucial for the viral transmission and 
This article is protected by copyright. All rights reserved.
viral replication in the SARS-CoV-2. Thus, the SARS-CoV-2 may be involved in the transfer of 
methyl groups for viral RNA capping from the host cell synthesized SAM. In the sequential step, 
SAM is converted into S- adenosylhomocysteine (SAH), which further in the presence of SAH 
hydrolase (SAHH) and from the removal of adenosine, produce an intermediate product called 
“homocysteine”, which is recycled by remethylation and trans-sulphuration pathway in the 
human body. 
Homocysteine has been under a lot of speculation since its discovery in 1932 6, which is known 
to be a sulphur containing, oxidative stress inducing agent. A recently discovered type of cell 
death known as ‘ferroptosis’ is predominantly seen associated with large amounts of 
accumulated iron particles along with reactive oxygen species (ROS) during the activity of cell 
death. This suggests that the occurrence of ferroptosis is iron-dependent. In addition, ferroptosis 
has crucial roles in the mechanisms involving multiple system diseases, namely, diseases of the 
nervous system, cardiovascular diseases, hepatic disorders, diseases of the gut, respiratory 
diseases, renal complications, pancreatic diseases, and so on. Increasing evidences have shown 
that ferroptosis may be accompanied by inflammation, and cells may activate their innate 
immune system factors through the stimulation of ferroptosis which play a key role in regulating 
inflammation damage, signal transduction and cell growth. Moreover,  metabolomic studies and 
assays that quantify metabolites revealed the involvement of SAHH, which is the key enzyme 
that assists in the SAH hydrolysis to homocysteine in the trans-sulfuration pathway 7. Moreover, 
elevated homocysteine levels have been linked to an increased risk of various pathological 
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processes in humans, including the potentiation of activated T lymphocyte proliferation, 
coronary artery diseases, peripheral artery diseases, renovascular diseases, ischemic stroke, 
venous thrombosis, neurodegenerative complication and elevated blood pressure during 
pregnancy 8. A recent study which was published in the Nature Communications journal 
explored the novel regulatory mechanisms that are directly involved with homocysteine that 
activate the angiotensin II type I receptor 9. Therefore, the SARS-CoV-2 takes advantage of the 
aggravated compensatory activation of ACE-2 enzyme, which is otherwise intended for multi-
organ protection 10, to enter into host cell for proliferation (Figure 1).  
To conclude, the above-mentioned findings further reveal new vital missing links in our current 
understanding of the mechanisms that lead to cell death triggered by ferroptotic stress in 
COVID-19 deaths. They further reveal the importance of homocysteine mediated trans-
sulfuration pathway in COVID-19 infection. Hence Vitamin B6, folic acid and Vitamin B12 
should be incorporated in the treatment regimen for SARS CoV-2 infections to suppress 
complications, as the virus mediates altered host cell metabolism. 
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Figure 1: SARS CoV-2 transform cellular metabolism mediated complication & assisted with Vit. B6/ B12 and 
folic acid in COVID-19 infection 
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